Bejon P

Gametocyte carriage in an era of changing malaria epidemiology: A 19-year analysis of a malaria longitudinal cohort.Muthui, M. K. Mogeni, P. Mwai, K. Nyundo, C. Macharia, A. Williams, T. N. Nyangweso, G. Wambua, J. Mwanga, D. Marsh, K. Bejon, P. Kapulu, M. C.
Wellcome Open Res, (2019). 4:66

A seven-year study on the effect of the pre-erythrocytic malaria vaccine candidate RTS,S/AS01 (E) on blood stage immunity in young Kenyan children.Ndungu, F. M. Mwacharo, J. Wambua, J. Njuguna, P. Marsh, K. Drakeley, C. Bejon, P.
Wellcome Open Res, (2019). 4:42

Effect of strikes by health workers on mortality between 2010 and 2016 in Kilifi, Kenya: a population-based cohort analysis.Ong'ayo, G. Ooko, M. Wang'ondu, R. Bottomley, C. Nyaguara, A. Tsofa, B. K. Williams, T. N. Bejon, P. Scott, J. A. G. Etyang, A. O.
Lancet Glob Health, (2019). 7:e961-e967

Repeated clinical malaria episodes are associated with modification of the immune system in children.Bediako, Y. Adams, R. Reid, A. J. Valletta, J. J. Ndungu, F. M. Sodenkamp, J. Mwacharo, J. Ngoi, J. M. Kimani, D. Kai, O. Wambua, J. Nyangweso, G. de Villiers, E. P. Sanders, M. Lotkowska, M. E. Lin, J. W. Manni, S. Addy, J. W. G. Recker, M. Newbold, C. Berriman, M. Bejon, P. Marsh, K. Langhorne, J.
BMC Med, (2019). 17:60

Oral versus Intravenous Antibiotics for Bone and Joint Infection.Li, H. K. Rombach, I. Zambellas, R. Walker, A. S. McNally, M. A. Atkins, B. L. Lipsky, B. A. Hughes, H. C. Bose, D. Kumin, M. Scarborough, C. Matthews, P. C. Brent, A. J. Lomas, J. Gundle, R. Rogers, M. Taylor, A. Angus, B. Byren, I. Berendt, A. R. Warren, S. Fitzgerald, F. E. Mack, D. J. F. Hopkins, S. Folb, J. Reynolds, H. E. Moore, E. Marshall, J. Jenkins, N. Moran, C. E. Woodhouse, A. F. Stafford, S. Seaton, R. A. Vallance, C. Hemsley, C. J. Bisnauthsing, K. Sandoe, J. A. T. Aggarwal, I. Ellis, S. C. Bunn, D. J. Sutherland, R. K. Barlow, G. Cooper, C. Geue, C. McMeekin, N. Briggs, A. H. Sendi, P. Khatamzas, E. Wangrangsimakul, T. Wong, T. H. N. Barrett, L. K. Alvand, A. Old, C. F. Bostock, J. Paul, J. Cooke, G. Thwaites, G. E. Bejon, P. Scarborough, M. Oviva Trial Collaborators
N Engl J Med, (2019). 380:425-436

Transmission and Age Impact the Risk of Developing Febrile Malaria in Children with Asymptomatic Plasmodium falciparum Parasitemia.Wamae, K. Wambua, J. Nyangweso, G. Mwambingu, G. Osier, F. Ndung'u, F. Bejon, P. Ochola-Oyier, L. I.
J Infect Dis, (2019). 219:936-944

Iron Status and Associated Malaria Risk Among African Children.Muriuki, J. M. Mentzer, A. J. Kimita, W. Ndungu, F. M. Macharia, A. W. Webb, E. L. Lule, S. A. Morovat, A. Hill, A. V. S. Bejon, P. Elliott, A. M. Williams, T. N. Atkinson, S. H.
Clin Infect Dis, (2019). 68:1807-1814

Ethical and scientific considerations on the establishment of a controlled human infection model for schistosomiasis in Uganda: report of a stakeholders' meeting held in Entebbe, Uganda.Elliott, A. M. Roestenberg, M. Wajja, A. Opio, C. Angumya, F. Adriko, M. Egesa, M. Gitome, S. Mfutso-Bengo, J. Bejon, P. Kapulu, M. Seager, Z. Lutalo, T. Nazziwa, W. B. Muwumuza, A. Yazdanbakhsh, M. Kaleebu, P. Kabatereine, N. Tukahebwa, E.
AAS Open Res, (2018). 1:2

KILchip v1.0: A Novel Plasmodium falciparum Merozoite Protein Microarray to Facilitate Malaria Vaccine Candidate Prioritization.Kamuyu, G. Tuju, J. Kimathi, R. Mwai, K. Mburu, J. Kibinge, N. Chong Kwan, M. Hawkings, S. Yaa, R. Chepsat, E. Njunge, J. M. Chege, T. Guleid, F. Rosenkranz, M. Kariuki, C. K. Frank, R. Kinyanjui, S. M. Murungi, L. M. Bejon, P. Farnert, A. Tetteh, K. K. A. Beeson, J. G. Conway, D. J. Marsh, K. Rayner, J. C. Osier, F. H. A.
Front Immunol, (2018). 9:2866

First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children.Tiono, A. B. Nebie, I. Anagnostou, N. Coulibaly, A. S. Bowyer, G. Lam, E. Bougouma, E. C. Ouedraogo, A. Yaro, J. B. B. Barry, A. Roberts, R. Rampling, T. Bliss, C. Hodgson, S. Lawrie, A. Ouedraogo, A. Imoukhuede, E. B. Ewer, K. J. Viebig, N. K. Diarra, A. Leroy, O. Bejon, P. Hill, A. V. S. Sirima, S. B.
PLoS One, (2018). 13:e0208328

Sonication versus Tissue Sampling for Diagnosis of Prosthetic Joint and Other Orthopedic Device-Related Infections.Dudareva, M. Barrett, L. Figtree, M. Scarborough, M. Watanabe, M. Newnham, R. Wallis, R. Oakley, S. Kendrick, B. Stubbs, D. McNally, M. A. Bejon, P. Atkins, B. A. Taylor, A. Brent, A. J.
J Clin Microbiol, (2018). 56:

Ethical considerations in Controlled Human Malaria Infection studies in low resource settings: Experiences and perceptions of study participants in a malaria Challenge study in Kenya.Njue, M. Njuguna, P. Kapulu, M. C. Sanga, G. Bejon, P. Marsh, V. Molyneux, S. Kamuya, D.
Wellcome Open Res, (2018). 3:39

Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study.Huttner, A. Agnandji, S. T. Combescure, C. Fernandes, J. F. Bache, E. B. Kabwende, L. Ndungu, F. M. Brosnahan, J. Monath, T. P. Lemaitre, B. Grillet, S. Botto, M. Engler, O. Portmann, J. Siegrist, D. Bejon, P. Silvera, P. Kremsner, P. Siegrist, C. A. Vebcon, Vsv, Ebovac Vsv-Eboplus Consortia
Lancet Infect Dis, (2018). 18:738-748

Single low-dose primaquine for blocking transmission of Plasmodium falciparum malaria - a proposed model-derived age-based regimen for sub-Saharan Africa.Taylor, W. R. Naw, H. K. Maitland, K. Williams, T. N. Kapulu, M. D'Alessandro, U. Berkley, J. A. Bejon, P. Okebe, J. Achan, J. Amambua, A. N. Affara, M. Nwakanma, D. van Geertruyden, J. P. Mavoko, M. Lutumba, P. Matangila, J. Brasseur, P. Piola, P. Randremanana, R. Lasry, E. Fanello, C. Onyamboko, M. Schramm, B. Yah, Z. Jones, J. Fairhurst, R. M. Diakite, M. Malenga, G. Molyneux, M. Rwagacondo, C. Obonyo, C. Gadisa, E. Aseffa, A. Loolpapit, M. Henry, M. C. Dorsey, G. John, C. Sirima, S. B. Barnes, K. I. Kremsner, P. Day, N. P. White, N. J. Mukaka, M.
BMC Med, (2018). 16:11

Variation in the effectiveness of insecticide treated nets against malaria and outdoor biting by vectors in Kilifi, Kenya.Kamau, A. Mwangangi, J. M. Rono, M. K. Mogeni, P. Omedo, I. Midega, J. Scott, J. A. G. Bejon, P.
Wellcome Open Res, (2017). 2:22

A Phase 2a Randomized Study to Evaluate the Safety and Immunogenicity of the 1790GAHB Generalized Modules for Membrane Antigen Vaccine against Shigella sonnei Administered Intramuscularly to Adults from a Shigellosis-Endemic Country.Obiero, C. W. Ndiaye, A. G. W. Scire, A. S. Kaunyangi, B. M. Marchetti, E. Gone, A. M. Schutte, L. D. Riccucci, D. Auerbach, J. Saul, A. Martin, L. B. Bejon, P. Njuguna, P. Podda, A.
Front Immunol, (2017). 8:1884

Trends in bednet ownership and usage, and the effect of bednets on malaria hospitalization in the Kilifi Health and Demographic Surveillance System (KHDSS): 2008-2015.Kamau, A. Nyaga, V. Bauni, E. Tsofa, B. Noor, A. M. Bejon, P. Scott, J. A. G. Hammitt, L. L.
BMC Infect Dis, (2017). 17:720

Examining the human infectious reservoir for Plasmodium falciparum malaria in areas of differing transmission intensity.Goncalves, B. P. Kapulu, M. C. Sawa, P. Guelbeogo, W. M. Tiono, A. B. Grignard, L. Stone, W. Hellewell, J. Lanke, K. Bastiaens, G. J. H. Bradley, J. Nebie, I. Ngoi, J. M. Oriango, R. Mkabili, D. Nyaurah, M. Midega, J. Wirth, D. F. Marsh, K. Churcher, T. S. Bejon, P. Sirima, S. B. Drakeley, C. Bousema, T.
Nat Commun, (2017). 8:1133

The prevalence of Plasmodium falciparum in sub-Saharan Africa since 1900.Snow, R. W. Sartorius, B. Kyalo, D. Maina, J. Amratia, P. Mundia, C. W. Bejon, P. Noor, A. M.
Nature, (2017). 550:515-518

A framework for Controlled Human Infection Model (CHIM) studies in Malawi: Report of a Wellcome Trust workshop on CHIM in Low Income Countries held in Blantyre, Malawi.Gordon, S. B. Rylance, J. Luck, A. Jambo, K. Ferreira, D. M. Manda-Taylor, L. Bejon, P. Ngwira, B. Littler, K. Seager, Z. Gibani, M. Gmeiner, M. Roestenberg, M. Mlombe, Y. Wellcome Trust, Chim workshop participants
Wellcome Open Res, (2017). 2:70